{"id":754713,"date":"2023-05-04T06:49:16","date_gmt":"2023-05-04T10:49:16","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/"},"modified":"2023-05-04T06:49:16","modified_gmt":"2023-05-04T10:49:16","slug":"immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/","title":{"rendered":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023"},"content":{"rendered":"<h2>\nConference Call Scheduled for Friday, May 12, 2023 at 9:00 AM ET<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">PORTLAND, Maine, May  04, 2023  (GLOBE NEWSWIRE) &#8212; <strong>ImmuCell Corporation (Nasdaq:\u00a0ICCC) <\/strong>(\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2023 after the market closes on Thursday, May 11, 2023.<\/p>\n<p>The Company has scheduled a conference call the next morning, Friday, May 12, 2023, at 9:00 AM ET to review its first quarter financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM ET. A teleconference replay of the call will be available until May 19, 2023 at (877) 344-7529 (toll free) or (412) 317-0088 (international), utilizing replay access code #3163870.<\/p>\n<p>The Company expects to file its Quarterly Report on Form 10-Q after the market closes on Thursday, May 11, 2023. The Company anticipates no change to the preliminary sales results for the first quarter of 2023 that were disclosed on April 5, 2023.<\/p>\n<p>Investors are encouraged to review the Company\u2019s updated Corporate Presentation slide deck that provides an overview of the Company\u2019s business which can be accessed under the \u201cInvestors\u201d tab of the Company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4niyCTw7vjUxwxIk21tzJjh2wCIAQ7m-TKrflU7IvGk4EWqz-3CT6e-nK9tPE845aihz7OO5mFdEZ7P5tyh7kw==\" rel=\"nofollow noopener\" target=\"_blank\">www.immucell.com<\/a>, or by request to the Company, after the market closes on Thursday, May 11, 2023.<\/p>\n<p>\n        <strong><br \/>\n          <u>About ImmuCell:<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>ImmuCell Corporation&#8217;s (<strong>Nasdaq: ICCC<\/strong>) purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef calves.\u00a0 ImmuCell manufactures and markets <strong>First Defense<\/strong><sup>\u00ae<\/sup>, providing <strong>Immediate Immunity<\/strong>\u2122 to newborn dairy and beef calves, and is in the late stages of developing <strong>Re-Tain<\/strong><sup>\u00ae<\/sup>, a novel treatment for subclinical mastitis in dairy cows without a milk discard requirement that provides an alternative to traditional antibiotics. Press releases and other information about the Company are available at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=U_tBp7EeLBqLj-13F4UtEb9uBENxSKVm4dHyX42k07piCxN7GHSUYFtBlkoGovJvawcM-oKt-ujR1Ew5RK4Cz7r2ZtSU5UB6JJLlIU3rghc=\" rel=\"nofollow noopener\" target=\"_blank\"><u>http:\/\/www.immucell.com<\/u><\/a>.<\/p>\n<p>Contacts:\u00a0\u00a0\u00a0\u00a0<br \/>Michael F. Brigham, President and CEO \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>ImmuCell Corporation \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>(207) 878-2770<\/p>\n<p>Joe Diaz, Robert Blum and Joe Dorame \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Lytham Partners, LLC \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>(602) 889-9700 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EbozBE2WzXEBscW7I6ZBB6rIw3Uu09KBYdfd2TUM5U1PDrunZA7O8EiRB_SNYVrwLrHjIWcz8gugDUGJ3c8cMhJkhk_LvQC18bUuu9XoWNI=\" rel=\"nofollow noopener\" target=\"_blank\">iccc@lythampartners.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YTk1Mzg3MGQtOTdjYy00MGE5LTkzYjAtMzg2ZjVmNWIxNGQzLTExMDEzODA=\/tiny\/ImmuCell-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Conference Call Scheduled for Friday, May 12, 2023 at 9:00 AM ET PORTLAND, Maine, May 04, 2023 (GLOBE NEWSWIRE) &#8212; ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2023 after the market closes on Thursday, May 11, 2023. The Company has scheduled a conference call the next morning, Friday, May 12, 2023, at 9:00 AM ET to review its first quarter financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-754713","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Conference Call Scheduled for Friday, May 12, 2023 at 9:00 AM ET PORTLAND, Maine, May 04, 2023 (GLOBE NEWSWIRE) &#8212; ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2023 after the market closes on Thursday, May 11, 2023. The Company has scheduled a conference call the next morning, Friday, May 12, 2023, at 9:00 AM ET to review its first quarter financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM &hellip; Continue reading &quot;ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-04T10:49:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023\",\"datePublished\":\"2023-05-04T10:49:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/\"},\"wordCount\":340,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/\",\"name\":\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=\",\"datePublished\":\"2023-05-04T10:49:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/","og_locale":"en_US","og_type":"article","og_title":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023 - Market Newsdesk","og_description":"Conference Call Scheduled for Friday, May 12, 2023 at 9:00 AM ET PORTLAND, Maine, May 04, 2023 (GLOBE NEWSWIRE) &#8212; ImmuCell Corporation (Nasdaq:\u00a0ICCC) (\u201cImmuCell\u201d or the \u201cCompany\u201d), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, expects to report unaudited financial results for the quarter ended March 31, 2023 after the market closes on Thursday, May 11, 2023. The Company has scheduled a conference call the next morning, Friday, May 12, 2023, at 9:00 AM ET to review its first quarter financial results. Interested parties can access the conference call by dialing (844) 855-9502 (toll free) or (412) 317-5499 (international) at 9:00 AM &hellip; Continue reading \"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-04T10:49:16+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023","datePublished":"2023-05-04T10:49:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/"},"wordCount":340,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/","name":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=","datePublished":"2023-05-04T10:49:16+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgzMTQ5MiM1NTczODY0IzIwODk4MDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ImmuCell to Announce Unaudited Financial Results for\u00a0the Quarter Ended March 31, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=754713"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/754713\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=754713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=754713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=754713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}